Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

Clinical trial NCT07555431 · RECRUITING

Trial details

NCT number: NCT07555431
Sponsor: Carlos Brites
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HTLV-1 Infection HTLV I Associated Myelopathies HTLV I Associated T Cell Leukemia Lymphoma Neuritis

Start date: 2026-05-07
Primary completion: 2028-05-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.